Stephen Dow is listed as a director on 3 SEC Form D filings by 1 issuer between Jun 2009 and Aug 2009: LIMERICK BIOPHARMA INC (San Francisco, CA — pharmaceuticals — 2009; $15.4M reported sold to 17 investors).
What this means One deal on file with the SEC, filed Aug 2009. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Asha Rajagopal (3 shared filings), Corey Goodman (3 shared filings), Scott Minick (3 shared filings), Wendye Robbins (3 shared filings) and Chad Waite (2 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Stephen. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name, 2 bankruptcy cases matching the name listed in Key records below.
What this means 4 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Stephen Dow and found 6 differences: Offering amount changed between filings; Stephen Dow is written 2 different ways on the filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.